Evidence map›Paper›PMID 40270851›Full record

ArticleAnnals of cardiothoracic surgery2025

Transcatheter aortic valve replacement explant various techniques.

Alexander A Brescia, Puja Kachroo, Tsuyoshi Kaneko

Abstract readEditorial
In one paragraph

Article in Annals of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Managing Transcatheter Aortic Valve Failure.Structural heart : the journal of the Heart Team · 2026
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexander A BresciaDivision of Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Puja KachrooDivision of Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Tsuyoshi KanekoDivision of Cardiothoracic Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgical aortic valve replacement (SAVR) has long been the gold standard for treating significant aortic valve dysfunction. Since the introduction of transcatheter aortic valve replacement (TAVR) in 2011, the number of TAVRs has grown rapidly, surpassing SAVR volumes by 2018 and now accounting for approximately 80% of all aortic valve replacements (AVRs) performed in the United States. In conjunction with the rapid expansion of TAVR, the number of TAVR valves requiring surgical explantation (TAVR-explant) has also increased due to procedure-related failure, endocarditis, structural valve degeneration with unfavorable anatomy for redo-TAVR, paravalvular leak, delayed migration, or prosthesis-patient mismatch. Often involving concomitant cardiac surgery, TAVR-explant has been associated with higher operative mortality than redo-SAVR. TAVR-explant is currently the fastest-growing cardiac procedure in the United States and is expected to continue growing, especially as TAVR is increasingly used for lower surgical risk and younger patients. Accordingly, describing and disseminating a standardized set of technical principles for performing TAVR-explant is essential for preparing all cardiac surgeons to appropriately treat these patients. TAVR-explant requires a comprehensive preoperative clinical and cross-sectional imaging assessment to plan an effective operation, including cannulation, aortotomy, explantation, and implantation strategies. Particular considerations for self-expanding and balloon-expandable TAVR valves are important for guiding the operation and optimizing outcomes. Special considerations, such as the need for concomitant aortic, coronary, or mitral valve surgery and the presence of snorkel coronary artery stents adjacent to the TAVR valve, must be considered and addressed at the time of TAVR-explant surgery. Currently, TAVR-explant confers a high operative mortality and is performed at very low volumes per surgeon. As this operation becomes increasingly common, it will become essential for all cardiac surgeons to understand and implement the operation's various techniques to optimize patient outcomes.

Indexed as

aortic stenosisendocarditissurgical aortic valve replacement (SAVR)Transcatheter aortic valve replacement (TAVR)

Identifiers

PMID40270851
PMCPMC12013762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.